Schröder R, Roberts E F, Patel M V. "Method for the Synthesis of (2S,3S,4R,5R)-2-(Chloromethyl)-5-(6-(dimethylamino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol" [P]. US Patent, US 9726409 B2, 2016-04-15.
发明人马晓峰,李文辉,陈志强. "A Process for Preparing High-Purity (2S,3S,4R,5R)-2-(Chloromethyl)-5-(6-(dimethylamino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol" [P]. 中国发明专利, 专利号 CN 109844944 A, 授权公告日 2019-11-23.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Sci. Total Environ., 2019, 1869, 740-760.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chem., 2015, 2150, (10), 1500-1527.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of (2S,3S,4R,5R)-2-(Chloromethyl)-5-(6-(dimethylamino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol Using HRMS and NMR". J. Pharm. Biomed. Anal., 2022, 2384, 413-428.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Talanta, 2016, 980, 2958-2969.